Emerging immunotherapies in multiple myeloma

This review summarises evidence of various immunotherapies (including chimeric antigen receptor T cells, bispecific antibodies, antibody drug conjugates & checkpoint inhibitors), mechanism of action and data from clinical trials regarding safety and efficacy.

British Medical Journal